F10 and deep vein thrombosis: Patients with life-threatening traumatic or spontaneous intracranial bleeds in the setting of FXai (apixaban or rivaroxaban) use: N=44 (T=28, C=16); male: T=61%, C=69%; female: T=39%, C=31%; age (median, IQR) T: 78 (70–87), C: 80 (74–84); GCS on admission (median, IQR), T: 14 (11–15), C: 14 (7–15); indication for anticoagulation: T: Afib 21/28, DVT 6/28, other 1/28 C: Afib 13/16, DVT 3/16; FXa inhibitor: T: apixaban 19, rivaroxaban 9, C: apixaban 12, rivaroxaban 4